Skip to main content
. 2015 Apr 2;6(17):14953–14969. doi: 10.18632/oncotarget.3621

Figure 3. Combining GSI-I and BTZ induces synergistic inhibitory effects in T-LPN.

Figure 3

A. Compared with a single drug, combined treatment with GSI-I with BTZ, induced significant decrease in the viability of Jurkat, MOLT-4, HuT 78, and H9 cells at 48 h. Data represent means ± SE from three independent experiments. B. Isobolographic curves illustrate that majority of the data points are lying to the left of the envelope of additivity (light blue area), indicating that combining GSI-I and BTZ induces synergistic effects in T-LPN cells.